The research found that while the drug recombinant human erythropoietin – commonly known as EPO – improved high-intensity lab test scores, it barely affected endurance and road race performances. (Source: AP) The research found that while the drug recombinant human erythropoietin – commonly known as EPO – improved high-intensity lab test scores, it barely affected endurance and road race performances. (Source: AP)Cyclists considering turning to blood doping to boost their racing speeds may find it does little for their performance, according to the results of a rare study published on Friday. The second, similar to a time trial, was a 45-minute lab-based endurance test at the highest power output. The third test, 12 days after the final injections, involved a 110-km (68-mile) ride followed by a 21.5-km road race up Mont Ventoux, which often features in the Tour de France.

Source: Indian Express June 30, 2017 11:48 UTC